These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3477318)

  • 1. Effectiveness of scalp cooling in reducing alopecia caused by epirubicin treatment of advanced breast cancer.
    Robinson MH; Jones AC; Durrant KD
    Cancer Treat Rep; 1987 Oct; 71(10):913-4. PubMed ID: 3477318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scalp cooling by cold air for the prevention of chemotherapy-induced alopecia.
    Hillen HF; Breed WP; Botman CJ
    Neth J Med; 1990 Dec; 37(5-6):231-5. PubMed ID: 2074916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of scalp hypothermia to prevent hair loss when cyclophosphamide is added to doxorubicin and vincristine.
    Middleton J; Franks D; Buchanan RB; Hall V; Smallwood J; Williams CJ
    Cancer Treat Rep; 1985 Apr; 69(4):373-5. PubMed ID: 3995509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scalp cooling has no place in the prevention of alopecia in adjuvant chemotherapy for breast cancer.
    Tollenaar RA; Liefers GJ; Repelaer van Driel OJ; van de Velde CJ
    Eur J Cancer; 1994; 30A(10):1448-53. PubMed ID: 7833100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention of adriamycin-induced alopecia by scalp hypothermia with a deep-frozen Duncool-Cap].
    Konishi Y; Kuroki T
    Gan To Kagaku Ryoho; 1988 Nov; 15(11):3081-5. PubMed ID: 3190248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of doxorubicin-induced alopecia by scalp cooling in patients with advanced breast cancer.
    Anderson JE; Hunt JM; Smith IE
    Br Med J (Clin Res Ed); 1981 Feb; 282(6262):423-4. PubMed ID: 6780057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerance of a scalp-cooling system for prevention of hair loss and the experience of breast cancer patients treated by adjuvant chemotherapy.
    Protière C; Evans K; Camerlo J; d'Ingrado MP; Macquart-Moulin G; Viens P; Maraninchi D; Genre D
    Support Care Cancer; 2002 Oct; 10(7):529-37. PubMed ID: 12324807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ineffectiveness of scalp hypothermia in the prevention of alopecia in patients treated with doxorubicin and cisplatin combinations.
    Wheelock JB; Myers MB; Krebs HB; Goplerud DR
    Cancer Treat Rep; 1984 Nov; 68(11):1387-8. PubMed ID: 6541971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pneumatic cold cap for the prevention of doxorubicin-induced alopecia].
    Samonigg H; Fereberger W; Biffl E
    Wien Med Wochenschr; 1984 Nov; 134(21):467-70. PubMed ID: 6516423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of scalp metastases in breast cancer: a retrospective cohort study in women who were offered scalp cooling.
    Lemieux J; Amireault C; Provencher L; Maunsell E
    Breast Cancer Res Treat; 2009 Dec; 118(3):547-52. PubMed ID: 19241158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicentre study to determine the efficacy and patient acceptability of the Paxman Scalp Cooler to prevent hair loss in patients receiving chemotherapy.
    Massey CS
    Eur J Oncol Nurs; 2004 Jun; 8(2):121-30. PubMed ID: 15171971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of scalp cooling during anthracycline containing chemotherapy depend on scalp skin temperature.
    Komen MMC; Smorenburg CH; Nortier JWR; van der Ploeg T; van den Hurk CJG; van der Hoeven JJM
    Breast; 2016 Dec; 30():105-110. PubMed ID: 27689316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonging the duration of post-infusion scalp cooling in the prevention of anthracycline-induced alopecia: a randomised trial in patients with breast cancer treated with adjuvant chemotherapy.
    Komen MMC; van den Hurk CJG; Nortier JWR; van der Ploeg T; Nieboer P; van der Hoeven JJM; Smorenburg CH
    Support Care Cancer; 2019 May; 27(5):1919-1925. PubMed ID: 30206728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of scalp cooling on chemotherapy-induced alopecia, wig use and hair growth of patients with cancer.
    van den Hurk CJ; van den Akker-van Marle ME; Breed WP; van de Poll-Franse LV; Nortier JW; Coebergh JW
    Eur J Oncol Nurs; 2013 Oct; 17(5):536-40. PubMed ID: 23571182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scalp hypothermia to prevent adriamycin-induced hair loss.
    Hunt JM; Anderson JE; Smith IE
    Cancer Nurs; 1982 Feb; 5(1):25-31. PubMed ID: 6917775
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial.
    Nangia J; Wang T; Osborne C; Niravath P; Otte K; Papish S; Holmes F; Abraham J; Lacouture M; Courtright J; Paxman R; Rude M; Hilsenbeck S; Osborne CK; Rimawi M
    JAMA; 2017 Feb; 317(6):596-605. PubMed ID: 28196254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypothermia: scalp cooling for the prevention of cytostatic-induced hair loss].
    Kiser J; Jungi E; Winkler L; Dubach C; Lampietti R; Salchli S; Heckendorn V
    Krankenpfl Soins Infirm; 1982 Dec; (12):29-32. PubMed ID: 6312166
    [No Abstract]   [Full Text] [Related]  

  • 18. The effectiveness of scalp cooling in preventing alopecia for patients receiving epirubicin and docetaxel.
    Macduff C; Mackenzie T; Hutcheon A; Melville L; Archibald H
    Eur J Cancer Care (Engl); 2003 Jun; 12(2):154-61. PubMed ID: 12787013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Scalp Cooling in Preventing Chemotherapy-Induced Alopecia in Breast Cancer Patients Receiving Adjuvant Docetaxel and Cyclophosphamide Chemotherapy.
    Cigler T; Isseroff D; Fiederlein B; Schneider S; Chuang E; Vahdat L; Moore A
    Clin Breast Cancer; 2015 Oct; 15(5):332-4. PubMed ID: 25749072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scalp hypothermia in the prevention of chemotherapy-induced alopecia.
    Vendelbo Johansen L
    Acta Radiol Oncol; 1985; 24(2):113-6. PubMed ID: 2988271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.